Given that rhabdoid tumor cell lines are susceptible to BRD9 inhibition [30,31], we sought to investigate the direct targets of BRD9 in mock-treated cell lines (which model the cancerous state) by ChIP-seq. Here, BRD9 is linked to neoplasm.